Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

University of Illinois Chicago
Search
University of Illinois Chicago

Office of Continuing Education and Meeting Services

College of Pharmacy - Chicago | Rockford

UI Health is UIC’s academic health enterprise

Recently Approved Antimicrobials for the Treatment of HABP/VABP

Posted on March 06, 2021
Keith Rodvold

Author: 
Keith A. Rodvold, PharmD, FCCP, FIDSA
UIC Distinguished Professor
Co-Director, Section of Infectious Diseases Pharmacotherapy
Colleges of Pharmacy and Medicine
University of Illinois at Chicago

Disclosure (s):
Dr. Rodvold is a speaker for Merck, Shionogi, and The Medicine Company/Qpex Biopharma. He is a consultant for The Medicine Company/Qpex Biopharma and VenatoRx Pharmaceuticals. Program Chair, Dr. Danziger is a speaker for Paratek Pharma and Shionogi. Dr. Novak, CME Faculty Advisor, is a consultant for Viiv Pharmaceuticals and a principal investigator for Janssen. All other reviewers who contributed to this activity have no relevant financial relationships of interest to disclose.

Learning Objectives:

At the end of this knowledge-based activity, participating individuals should be able to:

  • Describe important pharmacological characteristics of recently approved antibiotics for the treatment of HABP/VABP.
  • Outline the significant features and differences between the antibiotics used to treat Gram-negative pathogens associated with HABP/VABP.
Target Audience: Pharmacists Fee: $5
Release Date: April 5, 2021 Expiration Date: April 5, 2023
Estimated time to complete: 0.5 hours CE: 0.5 contact hour (0.05 CEUs)

Go to activity

acpe
Continuing Education Statement: The University of Illinois at Chicago College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity has been assigned an ACPE Universal Activity Number 0016-0000-21-012-H01-P, for 0.5 contact hours (0.05 CEUs). Reading the learning objectives and faculty disclosures; participating in the entire knowledge-based activity, active learning activity, post-test (minimum score of 70% required; may be taken up to 3 times) and activity evaluation; estimating duration of time spent on the activity; and submitting NABP eProfile ID and MMDD are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor ™ within 30 days of the activity date, so pharmacists are required to provide their eProfile ID and date of birth (MMDD) at the time of the activity. Please contact pharmce@uic.edu if you do not see activity information listed within 30 days. For more information and to set up your e-Profile visit: www.MyCPEmonitor.net

Acknowledgments: This activity is supported by an educational grant by Shionogi Inc.

How to Earn Credit:
Participants must complete the activity as described in the Continuing Education Statement. To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click ‘Finish Attempt’, then click ‘Submit All and Finish’ at the bottom of the page. Your post-test will automatically be graded. If you successfully complete the post-test, a confirmation message will appear at the top of the page underneath your grade. You will have a chance to review the correct answers and answer rationale.

Hardware/Software and Internet Requirements can be found at https://pharmacyce.uic.edu/moodle/.

Provider Contact Information:
For general information please call the Office of Continuing Education and Meeting Services toll-free at (866) PHARM-CE (866-742-7623) or send an e-mail to: pharmce@uic.edu. Copyright © 2021– The Board of Trustees of the University of Illinois. All rights reserved. Reproduction in whole or in part without permission is prohibited. Privacy Policy

Modified on December 13, 2021